PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
The summary for the PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed): This Notice of Funding Opportunity (NOFO), issued by the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA), invites eligible United States small businesses to submit Small Business Innovation Research (SBIR) grant applications. United States small businesses that have the research capabilities and technological expertise to contribute to the R and D mission(s) of the NIH, CDC, and FDA awarding components identified in this NOFO are encouraged to submit SBIR grant applications in response to identified topics (see PHS 2022-2 SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, and FDA. This Parent Funding Opportunity Announcement does not accept clinical trials.
Federal Grant Title: | PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) |
Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PA-23-230 |
Type of Funding: | Grant |
CFDA Numbers: | 93.084, 93.173, 93.286, 93.846, 93.855, 93.859, 93.866 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | April 5th, 2024 |
Original Application Deadline: | April 5th, 2024 |
Posted Date: | July 12th, 2023 |
Creation Date: | July 12th, 2023 |
Archive Date: | May 11th, 2024 |
Total Program Funding: | |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
Last Updated: | July 12th, 2023 |
- Applicants Eligible for this Grant
- Small businesses
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
- Link to Full Grant Announcement
- https://grants.nih.gov/grants/guide/pa-files/PA-23-230.html
- Grant Announcement Contact
- NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires. - Similar Government Grants
- • Modeling Infectious Diseases in Healthcare (MInD Healthcare) to Improve Pathogen Preventio...
- • Enhanced Surveillance and Control of Endemic and Emerging Arboviruses in Puerto Rico
- • Develop and Test HIV Prevention Interventions for Black and Hispanic Gay, Bisexual, and Ot...
- • PEP Packs: Postexposure Prophylaxis Packs for Immediate Access to HIV and Sexually Transmi...
- • NCHHSTP Epidemiologic and Economic Modeling for HIV, Viral Hepatitis, STD, and TB
- • Impact of Japanese Encephalitis Vaccination in Cambodia
- • Clinical, Epidemiologic and Ecologic Factors Impacting the Burden and Distribution of Monk...
- • Reduction of Malaria in U.S. Residents Returning from Overseas Travel to Malaria-Endemic C...
- More Grants from the National Institutes of Health
- • New Investigator Gateway Awards for Collaborative T1D Research (R03 Clinical Trial Not All...
- • Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional)
- • Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- • Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)
- • NIA Predoctoral Fellowship Award to Promote Broad Participation in Translational Research ...